Suppr超能文献

干预措施以提高 COVID-19 疫苗接种率:范围综述。

Interventions to increase COVID-19 vaccine uptake: a scoping review.

机构信息

Cochrane Haematology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Faculty of Medicine and University Hospital Cologne, University of Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cochrane Haematology, Cologne, Germany.

出版信息

Cochrane Database Syst Rev. 2022 Aug 3;8(8):CD015270. doi: 10.1002/14651858.CD015270.

Abstract

BACKGROUND

Vaccines are effective in preventing severe COVID-19, a disease for which few treatments are available and which can lead to disability or death. Widespread vaccination against COVID-19 may help protect those not yet able to get vaccinated. In addition, new and vaccine-resistant mutations of SARS-CoV-2 may be less likely to develop if the spread of COVID-19 is limited. Different vaccines are now widely available in many settings. However, vaccine hesitancy is a serious threat to the goal of nationwide vaccination in many countries and poses a substantial threat to population health. This scoping review maps interventions aimed at increasing COVID-19 vaccine uptake and decreasing COVID-19 vaccine hesitancy.

OBJECTIVES

To scope the existing research landscape on interventions to enhance the willingness of different populations to be vaccinated against COVID-19, increase COVID-19 vaccine uptake, or decrease COVID-19 vaccine hesitancy, and to map the evidence according to addressed populations and intervention categories.

SEARCH METHODS

We searched Cochrane COVID-19 Study Register, Web of Science (Science Citation Index Expanded and Emerging Sources Citation Index), WHO COVID-19 Global literature on coronavirus disease, PsycINFO, and CINAHL to 11 October 2021.

SELECTION CRITERIA

We included studies that assess the impact of interventions implemented to enhance the willingness of different populations to be vaccinated against COVID-19, increase vaccine uptake, or decrease COVID-19 vaccine hesitancy. We included randomised controlled trials (RCTs), non-randomised studies of intervention (NRSIs), observational studies and case studies with more than 100 participants. Furthermore, we included systematic reviews and meta-analyses. We did not limit the scope of the review to a specific population or to specific outcomes assessed. We excluded interventions addressing hesitancy towards vaccines for diseases other than COVID-19.

DATA COLLECTION AND ANALYSIS

Data were analysed according to a protocol uploaded to the Open Science Framework. We used an interactive scoping map to visualise the results of our scoping review. We mapped the identified interventions according to pre-specified intervention categories, that were adapted to better fit the evidence. The intervention categories were: communication interventions, policy interventions, educational interventions, incentives (both financial and non-financial), interventions to improve access, and multidimensional interventions. The study outcomes were also included in the mapping. Furthermore, we mapped the country in which the study was conducted, the addressed population, and whether the design was randomised-controlled or not.

MAIN RESULTS

We included 96 studies in the scoping review, 35 of which are ongoing and 61 studies with published results. We did not identify any relevant systematic reviews. For an overview, please see the interactive scoping map (https://tinyurl.com/2p9jmx24) STUDIES WITH PUBLISHED RESULTS Of the 61 studies with published results, 46 studies were RCTs and 15 NRSIs. The interventions investigated in the studies were heterogeneous with most studies testing communication strategies to enhance COVID-19 vaccine uptake. Most studies assessed the willingness to get vaccinated as an outcome. The majority of studies were conducted in English-speaking high-income countries. Moreover, most studies investigated digital interventions in an online setting. Populations that were addressed were diverse. For example, studies targeted healthcare workers, ethnic minorities in the USA, students, soldiers, at-risk patients, or the general population.  ONGOING STUDIES Of the 35 ongoing studies, 29 studies are RCTs and six NRSIs. Educational and communication interventions were the most used types of interventions. The majority of ongoing studies plan to assess vaccine uptake as an outcome. Again, the majority of studies are being conducted in English-speaking high-income countries. In contrast to the studies with published results, most ongoing studies will not be conducted online. Addressed populations range from minority populations in the USA to healthcare workers or students. Eleven ongoing studies have estimated completion dates in 2022.   AUTHORS' CONCLUSIONS: We were able to identify and map a variety of heterogeneous interventions for increasing COVID-19 vaccine uptake or decreasing vaccine hesitancy. Our results demonstrate that this is an active field of research with 61 published studies and 35 studies still ongoing. This review gives a comprehensive overview of interventions to increase COVID-19 vaccine uptake and can be the foundation for subsequent systematic reviews on the effectiveness of interventions to increase COVID-19 vaccine uptake.  A research gap was shown for studies conducted in low and middle-income countries and studies investigating policy interventions and improved access, as well as for interventions addressing children and adolescents. As COVID-19 vaccines become more widely available, these populations and interventions should not be neglected in research.

AUTHORS CONCLUSIONS

We were able to identify and map a variety of heterogeneous interventions for increasing COVID-19 vaccine uptake or decreasing vaccine hesitancy. Our results demonstrate that this is an active field of research with 61 published studies and 35 studies still ongoing. This review gives a comprehensive overview of interventions to increase COVID-19 vaccine uptake and can be the foundation for subsequent systematic reviews on the effectiveness of interventions to increase COVID-19 vaccine uptake.  A research gap was shown for studies conducted in low and middle-income countries and studies investigating policy interventions and improved access, as well as for interventions addressing children and adolescents. As COVID-19 vaccines become more widely available, these populations and interventions should not be neglected in research.

摘要

背景

疫苗在预防 COVID-19 重症方面非常有效,目前针对 COVID-19 这种疾病,可用的治疗方法有限,且该疾病可能导致残疾或死亡。广泛接种 COVID-19 疫苗可能有助于保护那些尚未能够接种疫苗的人。此外,如果 COVID-19 的传播受到限制,新的和对疫苗具有抗性的 SARS-CoV-2 突变体可能不太可能出现。目前,许多地方都有不同的疫苗可供使用。然而,在许多国家,疫苗犹豫是实现全国性疫苗接种目标的严重威胁,对人群健康构成了重大威胁。本范围综述绘制了旨在提高不同人群接种 COVID-19 疫苗的意愿、增加 COVID-19 疫苗接种率或降低 COVID-19 疫苗犹豫率的干预措施。

目的

确定旨在提高不同人群接种 COVID-19 疫苗、增加 COVID-19 疫苗接种率或降低 COVID-19 疫苗犹豫率的干预措施的现有研究情况,并根据所针对的人群和干预类别绘制证据。

检索方法

我们检索了 Cochrane COVID-19 研究注册库、Web of Science(科学引文索引扩展版和新兴来源引文索引)、世界卫生组织 COVID-19 全球冠状病毒疾病文献、PsycINFO 和 CINAHL,检索日期截至 2021 年 10 月 11 日。

选择标准

我们纳入了评估为提高不同人群接种 COVID-19 疫苗、增加疫苗接种率或降低 COVID-19 疫苗犹豫率而实施的干预措施的影响的研究。我们纳入了随机对照试验(RCT)、非随机干预研究(NRSI)、观察性研究和 100 名以上参与者的病例研究。此外,我们还纳入了系统评价和荟萃分析。我们没有将综述范围限制在特定人群或特定评估结果上。我们排除了针对 COVID-19 以外疾病的疫苗犹豫干预措施。

数据收集和分析

我们根据上传到开放科学框架的方案对数据进行了分析。我们使用互动式范围图来可视化我们的范围综述结果。我们根据预先指定的干预类别对确定的干预措施进行了映射,这些类别经过了调整,以更好地适应证据。干预类别包括:沟通干预、政策干预、教育干预、激励(财务和非财务)、改善获取途径的干预以及多维干预。研究结果也被纳入了映射。此外,我们还映射了研究所在的国家、所针对的人群以及设计是否为随机对照。

主要结果

我们纳入了 96 项范围综述研究,其中 35 项正在进行,61 项研究有已发表的结果。我们没有发现任何相关的系统评价。有关概述,请参见互动范围图(https://tinyurl.com/2p9jmx24)。

具有已发表结果的研究

在 61 项具有已发表结果的研究中,46 项为 RCT,15 项为 NRSI。研究中调查的干预措施具有异质性,大多数研究都测试了提高 COVID-19 疫苗接种率的沟通策略。大多数研究都将接种意愿作为结果进行评估。大多数研究是在英语国家进行的,并且大多数研究都在网上环境中进行了数字干预。所针对的人群多种多样。例如,研究对象包括医护人员、美国少数民族、学生、军人、高危患者或一般人群。

正在进行的研究

在 35 项正在进行的研究中,29 项为 RCT,6 项为 NRSI。教育和沟通干预是最常用的干预类型。大多数正在进行的研究计划将疫苗接种率作为结果进行评估。同样,大多数正在进行的研究都是在英语国家进行的。与具有已发表结果的研究相比,大多数正在进行的研究将不会在网上进行。正在进行的研究对象包括美国的少数民族、医护人员或学生。有 11 项正在进行的研究预计在 2022 年完成。

作者结论

我们能够确定和绘制各种不同的干预措施,以提高 COVID-19 疫苗接种率或降低疫苗犹豫率。我们的研究结果表明,这是一个非常活跃的研究领域,有 61 项已发表的研究和 35 项正在进行的研究。本综述全面概述了提高 COVID-19 疫苗接种率的干预措施,可以作为后续评估提高 COVID-19 疫苗接种率的干预措施有效性的系统评价的基础。研究表明,在低收入和中等收入国家以及政策干预和改善获取途径的研究以及针对儿童和青少年的干预措施方面,研究存在差距。随着 COVID-19 疫苗的广泛使用,这些人群和干预措施不应在研究中被忽视。

相似文献

1
Interventions to increase COVID-19 vaccine uptake: a scoping review.
Cochrane Database Syst Rev. 2022 Aug 3;8(8):CD015270. doi: 10.1002/14651858.CD015270.
3
Improving vaccination uptake among adolescents.
Cochrane Database Syst Rev. 2020 Jan 17;1(1):CD011895. doi: 10.1002/14651858.CD011895.pub2.
4
Measures implemented in the school setting to contain the COVID-19 pandemic: a scoping review.
Cochrane Database Syst Rev. 2020 Dec 17;12(12):CD013812. doi: 10.1002/14651858.CD013812.
6
Physical interventions to interrupt or reduce the spread of respiratory viruses.
Cochrane Database Syst Rev. 2020 Nov 20;11(11):CD006207. doi: 10.1002/14651858.CD006207.pub5.
7
Physical interventions to interrupt or reduce the spread of respiratory viruses.
Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD006207. doi: 10.1002/14651858.CD006207.pub6.
8
Immunity after COVID-19 vaccination in people with higher risk of compromised immune status: a scoping review.
Cochrane Database Syst Rev. 2022 Aug 9;8(8):CD015021. doi: 10.1002/14651858.CD015021.
9
Workplace interventions to reduce the risk of SARS-CoV-2 infection outside of healthcare settings.
Cochrane Database Syst Rev. 2024 Apr 10;4(4):CD015112. doi: 10.1002/14651858.CD015112.pub3.
10
Interventions for improving coverage of childhood immunisation in low- and middle-income countries.
Cochrane Database Syst Rev. 2023 Dec 6;12(12):CD008145. doi: 10.1002/14651858.CD008145.pub4.

引用本文的文献

1
[Enlightenment through official vaccination communication: an experimental study comparing evidence-based fact boxes with nudges and advertising].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2025 Sep;68(9):1024-1034. doi: 10.1007/s00103-025-04109-2. Epub 2025 Aug 4.
2
COVID-19 vaccine hesitancy among Italian university students: Insights from history to shape the future.
Hum Vaccin Immunother. 2025 Dec;21(1):2506307. doi: 10.1080/21645515.2025.2506307. Epub 2025 Jun 18.
4
New COVID-19 vaccination recommendations in Spain: Optimizing for next seasons.
Enferm Infecc Microbiol Clin. 2025 Jan;43(1):36-46. doi: 10.1016/j.eimc.2024.08.012.
5
Unraveling Herpes Zoster Vaccine Hesitancy, Acceptance, and Its Predictors: Insights From a Scoping Review.
Public Health Rev. 2024 Jul 24;45:1606679. doi: 10.3389/phrs.2024.1606679. eCollection 2024.
7
Interventions to increase vaccination in vulnerable groups: rapid overview of reviews.
BMC Public Health. 2024 Jun 3;24(1):1479. doi: 10.1186/s12889-024-18713-5.
9
Study protocol: Project 2VIDA! SARS-CoV-2 vaccine intervention delivery for adults in Southern California.
Front Public Health. 2024 Mar 14;12:1291332. doi: 10.3389/fpubh.2024.1291332. eCollection 2024.
10
COVID-19 vaccine uptake among young adults: Influence of asthma and sociodemographic factors.
J Allergy Clin Immunol Glob. 2024 Feb 20;3(2):100231. doi: 10.1016/j.jacig.2024.100231. eCollection 2024 May.

本文引用的文献

3
Behavioral responses to risk promote vaccinating high-contact individuals first.
Syst Dyn Rev. 2022 Jul-Sep;38(3):246-263. doi: 10.1002/sdr.1714. Epub 2022 Aug 23.
5
Communicating about COVID-19 vaccine development and safety.
PLoS One. 2022 Aug 5;17(8):e0272426. doi: 10.1371/journal.pone.0272426. eCollection 2022.
6
Corowa-kun: A messenger app chatbot delivers COVID-19 vaccine information, Japan 2021.
Vaccine. 2022 Jul 30;40(32):4654-4662. doi: 10.1016/j.vaccine.2022.06.007. Epub 2022 Jun 8.
7
A randomized controlled trial of a video intervention shows evidence of increasing COVID-19 vaccination intention.
PLoS One. 2022 May 19;17(5):e0267580. doi: 10.1371/journal.pone.0267580. eCollection 2022.
8
Association between statewide financial incentive programs and COVID-19 vaccination rates.
PLoS One. 2022 Mar 30;17(3):e0263425. doi: 10.1371/journal.pone.0263425. eCollection 2022.
9
COVID-19 vaccination beliefs, attitudes, and behaviours among health and social care workers in the UK: A mixed-methods study.
PLoS One. 2022 Jan 24;17(1):e0260949. doi: 10.1371/journal.pone.0260949. eCollection 2022.
10
The Role of Incentives in Deciding to Receive the Available COVID-19 Vaccine in Israel.
Vaccines (Basel). 2022 Jan 4;10(1):77. doi: 10.3390/vaccines10010077.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验